This webinar featured Maurade Gormley, MSN, from New York University, who discussed the quantitative findings from her study titled, "Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors," which was supported by the Love Research Army.
This webinar featured Michael C. Robertson, PhD, MPH and Karen Basen-Engquist, PhD, MPH from the University of Texas, who conducted a study titled, "Physical Activity Intervention in Breast Cancer Survivors," which was supported by the Love Research Army. Dr. Robertson discussed the study's findings and answered questions from webinar attendees.
This webinar featured Lorraine Dean, ScD, and Tonia Poteat, PhD, of Johns Hopkins Bloomberg School of Public Health, who conducted a study titled, "Our Breast Health: The Access Study," which was supported by the Love Research Army. Dr. Dean and Dr. Poteat discuss the results of their study and answer questions from our Senior Director of Clinical Research, Leah Eshraghi, MPH, and webinar attendees.
This webinar featured panelists Dr. Susan Love, Michael Kovarik, Michael Singer, and Dr. Athena Starlard-Davenport. The panelists discussed the limitations met by people of minority backgrounds, such as the LGBTQ+ population and people of color, that often impede them from participating in breast cancer research studies.
This webinar featured Dr. Andrew T. Chan of Massachusetts General Hospital. He presented a call to action to use the COVID Symptom Tracker, an app that documents your symptoms daily in order to track the growth of COVID-19 across the country and discover how it is affecting people with cancer. Dr. Chan discusses the app with Dr. Susan Love, Crystal Hertz, and webinar attendees.
This webinar featured Dr. Manraj Kaur and Dr. Elena Tsangaris of Brigham and Women's Hospital and the Patient-Reported Outcomes, Values, and Experience (PROVE) Center at the Harvard Medical School Teaching Hospital. The researchers discussed their team's creation of the Breast-Q questionnaire, a patient-reported outcome measure that continues to advance clinical care and quality in breast cancer surgery. The discussion was held with Crystal Hertz and webinar attendees.